Index of reports
> Cases with Convulsion (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Symmetrel (Amantadine) where reactions include convulsion. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Symmetrel side effects in female
Reported by a physician from Japan on 2012-08-09
Patient: female, weighing 37.0 kg (81.4 pounds)
Reactions: Encephalitis, Altered State of Consciousness, Convulsion
Drug(s) suspected as cause:
Symmetrel
Dosage: 300 mg, unk
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-07-04
Comtan
Dosage: 300 mg, unk
Administration route: Oral
Indication: Parkinson's Disease
Other drugs received by patient: Selbex; Pramipexole Dihydrochloride; Zonisamide; Menest; Selegiline Hydrochloride; Isosorbide Mononitrate
Possible Symmetrel side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-18
Patient: female
Reactions: Altered State of Consciousness, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Symmetrel
Dosage: 100 mg
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-06-09
End date: 2011-06-22
Memantine HCL
Dosage: 5 mg
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-07-21
End date: 2011-07-27
Memantine HCL
Dosage: 10 mg
Administration route: Oral
Start date: 2011-07-28
End date: 2011-08-03
Memantine HCL
Dosage: 15 mg
Administration route: Oral
Start date: 2011-08-04
End date: 2011-08-10
Memantine HCL
Dosage: 20 mg
Administration route: Oral
Start date: 2011-08-11
End date: 2011-11-18
Symmetrel
Dosage: 50 mg
Administration route: Oral
Start date: 2011-06-23
End date: 2011-10-26
Symmetrel
Dosage: 100 mg
Administration route: Oral
Start date: 2011-10-27
Other drugs received by patient: Rozerem; Aricept
Possible Symmetrel side effects in 86 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-24
Patient: 86 year old female
Reactions: Decreased Activity, Altered State of Consciousness, Somnolence, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Memantine Hydrochloride
Dosage: 20 mg (20 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-08-11
End date: 2011-11-18
Symmetrel
Dosage: 100 mg (50 mg, 2 in 1 d), oral 50 mg (25 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-06-09
End date: 2011-06-22
Symmetrel
Dosage: 100 mg (50 mg, 2 in 1 d), oral 50 mg (25 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-06-23
End date: 2011-10-26
Memantine Hydrochloride
Dosage: 5 mg (5 mg, 1 in 1 d), oral 10 mg (10 mg, 1 in 1 d), oral 15 mg (15 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-08-04
End date: 2011-08-10
Memantine Hydrochloride
Dosage: 5 mg (5 mg, 1 in 1 d), oral 10 mg (10 mg, 1 in 1 d), oral 15 mg (15 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-07-28
End date: 2011-08-03
Memantine Hydrochloride
Dosage: 5 mg (5 mg, 1 in 1 d), oral 10 mg (10 mg, 1 in 1 d), oral 15 mg (15 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-07-21
End date: 2011-07-27
Symmetrel
Dosage: 100 mg (50 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-10-27
Other drugs received by patient: Rozerem (Ramelteon) (Ramelteon); Aricept D (Donepezil Hydrochloride) (Donepezil Hydrochloride)
Possible Symmetrel side effects in 86 year old female
Reported by a pharmacist from Germany on 2012-02-17
Patient: 86 year old female
Reactions: Decreased Activity, Altered State of Consciousness, Somnolence, Sluggishness, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Symmetrel
Dosage: 100;50 mg (50 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-06-09
End date: 2011-06-22
Symmetrel
Dosage: 100;50 mg (50 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-06-23
End date: 2011-10-26
Memantine Hydrochloride
Dosage: 5;10;15 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-08-04
End date: 2011-08-10
Memantine Hydrochloride
Dosage: 5;10;15 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-07-21
End date: 2011-07-27
Memantine Hydrochloride
Dosage: 5;10;15 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-07-28
End date: 2011-08-03
Memantine Hydrochloride
Dosage: 20 mg (20 mg 1 in 1 d), oral
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2011-08-11
End date: 2011-11-18
Symmetrel
Dosage: 100 mg (50 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2011-10-27
Other drugs received by patient: Aricept; Rozerem
|